Dan Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dan Jin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Guanghai Yan
Jilin Key Laboratory for Immune and Targeting Research on Common Allergic Diseases, Yanbian University, Yanji, Jilin, China
1 shared publication - Jienan Kong
Department of Pathology & Cancer Research Center, Yanbian University Medical College, Yanji 133002, China
1 shared publication - Lijuan Lin
Department of Medical Imaging, College of Medicine, Eastern Liaoning University, Dandong, China
1 shared publication - Tiefeng Jin
Department of Central Laboratory, Yanbian University Hospital, Yanji, China; Department of Pathology and Cancer Research Center, Yanbian University, Yanji, China; Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, Yanji, China
1 shared publication - Xiangshan Ren
Key Laboratory of Natural Medicines of the Changbai Mountain, Yanbian University, Ministry of Education, Yanji, China
1 shared publication - Yue Ma
Department of Pathology & Cancer Research Center, Yanbian University Medical College, Yanji, China
1 shared publication
Latest Publications
- Open Access
- 9 June 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 414
NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix
NQO1 (NAD(P)H: quinone oxidoreductase-1), located on chromosome 16q22, functions primarily to protect normal cells from oxidant stress and electrophilic attack. Recent studies have revealed that NQO1 is expressed at a high level in most human solid tumors including those of the colon, breast, pancreas, ovaries and thyroid, and it has also been detected following the induction of cell cycle progression and proliferation of melanoma cells. In this study, we aimed to investigate the clinicopathological significance of upregulated NQO1 protein expression in squamous cell carcinomas (SCCs) of the uterine cervix. The localization of the NQO1 protein was determined in the SiHa cervical squamous cancer cell line using immunofluorescence (IF) staining, and immunohistochemical (IHC) staining performed on paraffin-embedded cervical SCC specimens from 177 patients. For comparison, 94 cervical intraepithelial neoplasia (CIN) and 25 normal cervical epithelia samples were also included. QRT-PCR was performed on RNA from fresh tissues to detect NQO1 mRNA expression levels, and HPV infection status was genotyped using oligonucleotide microarray. Disease-free survival (DFS) and 5-year overall survival (OS) rates for all cervical SCC patients were calculated using the Kaplan–Meier method, and univariate and multivariate analysis was performed using the Cox proportional hazards regression model. The NQO1 protein showed a mainly cytoplasmic staining pattern in cervical cancer cells, and only three cases of cervical SCC showed a nuclear staining pattern. The strongly positive rate of NQO1 protein expression was significantly higher in cervical SCCs and CINs than in normal cervical epithelia. High-level NQO1 expression was closely associated with poor differentiation, late-stage, lymph node metastasis and high-risk for HPV infection. Additionally, high-level NQO1 expression was associated with lower DFS and 5-year OS rates, particularly for patients with early-stage cervical SCCs. Furthermore, Cox analysis revealed that NQO1 expression emerged as a significant independent hazard factor for DFS rate in patients with cervical SCC. NQO1 overexpression might be an independent biomarker for prognostic evaluation of cervical SCCs.
- 9 June 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 414
Open AccessNQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix
NQO1 (NAD(P)H: quinone oxidoreductase-1), located on chromosome 16q22, functions primarily to protect normal cells from oxidant stress and electrophilic attack. Recent studies have revealed that NQO1 is expressed at a high level in most human solid tumors including those of the colon, breast, pancreas, ovaries and thyroid, and it has also been detected following the induction of cell cycle progression and proliferation of melanoma cells. In this study, we aimed to investigate the clinicopathological significance of upregulated NQO1 protein expression in squamous cell carcinomas (SCCs) of the uterine cervix. The localization of the NQO1 protein was determined in the SiHa cervical squamous cancer cell line using immunofluorescence (IF) staining, and immunohistochemical (IHC) staining performed on paraffin-embedded cervical SCC specimens from 177 patients. For comparison, 94 cervical intraepithelial neoplasia (CIN) and 25 normal cervical epithelia samples were also included. QRT-PCR was performed on RNA from fresh tissues to detect NQO1 mRNA expression levels, and HPV infection status was genotyped using oligonucleotide microarray. Disease-free survival (DFS) and 5-year overall survival (OS) rates for all cervical SCC patients were calculated using the Kaplan–Meier method, and univariate and multivariate analysis was performed using the Cox proportional hazards regression model. The NQO1 protein showed a mainly cytoplasmic staining pattern in cervical cancer cells, and only three cases of cervical SCC showed a nuclear staining pattern. The strongly positive rate of NQO1 protein expression was significantly higher in cervical SCCs and CINs than in normal cervical epithelia. High-level NQO1 expression was closely associated with poor differentiation, late-stage, lymph node metastasis and high-risk for HPV infection. Additionally, high-level NQO1 expression was associated with lower DFS and 5-year OS rates, particularly for patients with early-stage cervical SCCs. Furthermore, Cox analysis revealed that NQO1 expression emerged as a significant independent hazard factor for DFS rate in patients with cervical SCC. NQO1 overexpression might be an independent biomarker for prognostic evaluation of cervical SCCs.